Your browser doesn't support javascript.
loading
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.
Martin, J E; Khalife-Hachem, S; Grinda, T; Kfoury, M; Garciaz, S; Pasquier, F; Vargaftig, J; Uzunov, M; Belhabri, A; Bertoli, S; Cotteret, S; Vergé, V; Renneville, A; Rosselli, F; Antony-Debre, I; Rouleau, E; Salviat, F; Caron, O; Delaloge, S; Pautier, P; Etienne, G; Recher, C; Vey, N; De Botton, S; Leary, A; Marzac, C; Micol, J B.
Afiliação
  • Martin JE; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Khalife-Hachem S; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Grinda T; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Kfoury M; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM U981, Villejuif, France.
  • Garciaz S; Institut Paoli Calmettes, Marseille, France; Cancer Research Center of Marseille, INSERM U1068, Aix-Marseille University, Marseille, France.
  • Pasquier F; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Vargaftig J; Institut Curie, Paris, France.
  • Uzunov M; Hopital Pitié-Salpêtrière, Paris, France.
  • Belhabri A; Department of Oncology, Centre Leon Berard, Lyon, France.
  • Bertoli S; Hematology Department, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
  • Cotteret S; Department of Biology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Vergé V; Department of Biology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Renneville A; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Rosselli F; CNRS UMR9019, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France.
  • Antony-Debre I; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Rouleau E; Department of Biology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Salviat F; Department of Biostatistics, Université Paris-Saclay, Villejuif, France.
  • Caron O; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Delaloge S; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Pautier P; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Etienne G; Institute Bergonie, Hôpital Haut-Leveque, Pessac, France.
  • Recher C; Hematology Department, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
  • Vey N; Institut Paoli Calmettes, Marseille, France; Cancer Research Center of Marseille, INSERM U1068, Aix-Marseille University, Marseille, France.
  • De Botton S; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Leary A; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM U981, Villejuif, France; Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Marzac C; Department of Biology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Micol JB; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address:
Ann Oncol ; 32(8): 1046-1048, 2021 08.
Article em En | MEDLINE | ID: mdl-34107346
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França